Avaleht › Haavandiline koliit › Illinois
Haavandiline koliit kliinilised uuringud osariigis Illinois
24 uuringut haiguse Haavandiline koliit jaoks otsivad osalejaid osariigis Illinois.
Linnad osariigis Illinois
Ametlik uuringutekst (inglise keeles)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Midwest Digestive Health & Nutrition /ID# 285250, Des Plaines
- Gi Alliance - Glenview /ID# 283932, Glenview
- Illinois Gastroenterology Group /ID# 283933, Gurnee
- ja veel 1
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Yapp, Rockford M.D. (Private Practice), Downers Grove
- GI Alliance - Glenview, Glenview
- Gastroenterology and Internal Medicine Specialists, SC, Lake Barrington
- ja veel 3
VärbamineFaas 4
Vanused 18–80 · Kõik sood · Uuendatud 30. sept 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University of Chicago Medical Center /ID# 271588, Chicago
VärbamineFaas 3
Vanused 2–17 · Kõik sood · Uuendatud 30. sept 2026 · NCT07071519A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Northwestern University, Chicago
- Avicenna Clinical Research - SW Gastroenterology, Oak Lawn
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 30. sept 2026 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 038, Chicago
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 29. sept 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-005, Des Plaines
- Site US-007, Glenview
- Site US-020, Gurnee
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 29. sept 2026 · NCT07845487A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- University of Chicago Medical Center, Chicago
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06979336A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0101, Park Ridge
VärbamineFaas 2/3
Vanused 2–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Rush University Medical Center, Chicago
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Center for Gastrointestinal Health - Fairview Heights, Belleville
- Northwestern University, Chicago
- Midtown Gastroenterology and Liver Disease, Des Plaines
- ja veel 2
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Rush University Medical Center, Chicago
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
- Midwest Digestive Health & Nutrition, Des Plaines
- ja veel 1
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University of Chicago Medicine, Chicago
VärbamineFaas 4
Vanused 18–65 · Kõik sood · Uuendatud 21. sept 2026 · NCT06095128A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Illinois Gastroenterology Group - Gurnee, Gurnee
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 21. aug 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Rush University Medical Center - Site Number: 8400015, Chicago
- Midwest Digestive Health and Nutrition - Site Number: 8400136, Des Plaines
- GI Alliance - Glenview - Site Number: 8400068, Glenview
- ja veel 1
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 20. aug 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Chicago Medicine, Chicago
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 7. aug 2026 · NCT05230173An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
- Suburban Gastroenterology Ltd, Naperville
VärbamineVaatlusuuring
Vanused 18–64 · Kõik sood · Uuendatud 9. juuli 2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- University of Chicago Medical Center, Chicago
VärbamineFaas 2
Vanused 12–17 · Kõik sood · Uuendatud 8. juuli 2026 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Advocate Children's Hospital Park Ridge, Park Ridge
VärbamineFaas 3
Vanused 2–17 · Kõik sood · Uuendatud 22. juuni 2026 · NCT06405087Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
- Northwestern University, Chicago
VärbamineFaas 2
Vanused 18–85 · Kõik sood · Uuendatud 22. mai 2026 · NCT07427017A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Advocate Children's Hospital - Park Ridge - PIN, Park Ridge
VärbamineFaas 3
Vanused 2 ja vanemad · Kõik sood · Uuendatud 7. mai 2026 · NCT05442567STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
- University of Chicago, Chicago
Värbamine
Vanused 18–75 · Kõik sood · Uuendatud 6. apr 2026 · NCT06693310A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Glenview
- Mirador Therapeutics Selected Site, Gurnee
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 12. märts 2026 · NCT07113522Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Northwestern Medicine Lake Forest Hospital, Lake Forest
Värbamine
Vanused 18–85 · Kõik sood · Uuendatud 8. jaan 2026 · NCT05987852Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.